Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Symbol
BOLT on Nasdaq
Shares outstanding
1,912,224
Price per share
$5.47
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
602,538
Total reported value
$3,295,047
% of total 13F portfolios
0%
Share change
-259,998
Value change
-$1,398,347
Number of holders
21
Price from insider filings
$5.47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pivotal bioVenture Partners Fund I, L.P. 6.7% $700,555 128,119 Nan Fung Group Holdings Limited 05 Feb 2026
TANG CAPITAL MANAGEMENT LLC 3.5% -58% $355,790 -$531,990 66,879 -60% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025

As of 31 Dec 2025, 21 institutional investors reported holding 602,538 shares of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT). This represents 32% of the company’s total 1,912,224 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) together control 32% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Sofinnova Investments, Inc. 7.2% 137,721 0% 0.03% $753,058
Pivotal bioVenture Partners Investment Advisor LLC 4.9% 94,573 0% 0.2% $517,125
Vivo Capital, LLC 3.8% 72,414 -59% 0.03% $395,960
Nan Fung Group Holdings Ltd 3.1% 58,347 0% 0.29% $319,041
RENAISSANCE TECHNOLOGIES LLC 2.9% 55,025 +92% 0% $300,877
T3 Companies, LLC 2% 38,000 0% 0.27% $207,784
Board of Trustees of The Leland Stanford Junior University 1.9% 35,977 -0% 0.04% $196,722
Pfizer Inc 1.6% 31,305 0% 0.07% $171,176
NANO CAP NEW MILLENNIUM GROWTH FUND L P 1.1% 20,500 0% 0.1% $112,094
GEODE CAPITAL MANAGEMENT, LLC 0.98% 18,803 +1.5% 0% $103,058
Shay Capital LLC 0.8% 15,272 -4.3% 0.01% $83,507
VANGUARD GROUP INC 0.53% 10,179 -70% 0% $55,782
BlackRock, Inc. 0.51% 9,711 0% 0% $53,100
MORGAN STANLEY 0.16% 3,128 0% 0% $17,104
Tower Research Capital LLC (TRC) 0.04% 723 +179% 0% $3,953
UBS Group AG 0.03% 515 +17067% 0% $2,816
CITIGROUP INC 0.01% 256 0% $1,403
JPMORGAN CHASE & CO 0% 42 0% 0% $230
BANK OF AMERICA CORP /DE/ 0% 31 0% 0% $169
SBI Securities Co., Ltd. 0% 10 0% 0% $55
BARCLAYS PLC 0% 6 0% 0% $33
DRW Securities, LLC 0% 0 -100% $0
SAMSARA BIOCAPITAL, LLC 0% 0 -100% $0
TANG CAPITAL MANAGEMENT LLC 0% 0 -100% $0
SALEM INVESTMENT COUNSELORS INC 0% 0 -100% $0

Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 602,538 $3,295,047 -$1,398,347 $5.47 21
2025 Q3 804,036 $4,277,487 -$449,315 $5.32 24
2025 Q2 887,525 $5,096,477 +$5,096,477 $5.77 24